FGTI-2734

FGTI-2734 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:FGTI-2734
CAS:1247018-19-4
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:FGTI-2734
CAS:1247018-19-4
Purity:98.00% Package:1 mg;1 mL * 10mM (in DMSO);10 mg;100 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: LEAPCHEM CO., LTD.
Tel: +86-852-30606658
Email: market18@leapchem.com
Products Intro: Product Name:FGTI-2734
CAS:1247018-19-4
Purity:0 Package:1g; 5g; 25g; 1kg; 5kg; 25kg Remarks:0
Company Name: Aladdin Scientific
Tel: +1-833-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:FGTI-2734
CAS:1247018-19-4
Purity:99% Package:$150.9/5mg;$250.9/10mg;$500.9/25mg;$810.9/50mg;$1300.9/100mg;Bulk package Remarks:99%
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 15618227136
Email: info@SuperLan-chem.com
Products Intro: Product Name:FGTI-2734
CAS:1247018-19-4
Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
FGTI-2734 Basic information
Product Name:FGTI-2734
Synonyms:FGTI-2734;2-Pyridinesulfonamide, N-[2-[(4-cyano-2-fluorophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino]ethyl]-N-(cyclohexylmethyl)-;pancreatic,patient-derived,geranylgeranyl,farnesyl,inhibit,Farnesyl Transferase,mimetic,FGTI2734,Inhibitor,membrane,Ftase,FGTI-2734,KRAS,FGTI 2734,C-terminal,transferase,tumors,localization
CAS:1247018-19-4
MF:C26H31FN6O2S
MW:510.63
EINECS:
Product Categories:
Mol File:1247018-19-4.mol
FGTI-2734 Structure
FGTI-2734 Chemical Properties
Boiling point 770.1±70.0 °C(Predicted)
density 1.28±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:50.0(Max Conc. mg/mL);97.92(Max Conc. mM)
pka6.60±0.10(Predicted)
Safety Information
MSDS Information
FGTI-2734 Usage And Synthesis
DescriptionFGTI-2734 is a RAS C-terminal mimetic dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT-1) inhibitor. It can prevent membrane localization of KRAS, hence solving KRAS resistance problem and thwarting mutant KRAS patient-derived pancreatic tumors.
targetFGTI-2734 is a RAS C-terminal mimetic dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT-1) inhibitor with IC50s of 250 nM and 520 nM for FT and GGT-1, respectively.
FGTI-2734 Preparation Products And Raw materials
Tag:FGTI-2734(1247018-19-4) Related Product Information